FDA (CDER)
GUIDANCE FINAL
Submitting Clinical Trial Data to Evaluate the Ability to Operate a Motor Vehicle
Published: 10/20/2026Detected: 10/20/2026
Summary preview
Clarifies how to submit clinical trial data intended to support the ability to operate a motor vehicle, including expectations for generating and presenting evidence relevant to driving performance and safety.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountOfficial Source Document Source Verified
Access the original document directly from FDA CDER.
More from FDA (CDER)
- Regulatory Considerations for Prescription Drug Use-Related Software10/20/2026
- Safety Reporting Requirements for INDs and BA/BE Studies: Guidance for Industry and Investigators10/19/2026
- Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers10/9/2026
- Questions and Answers on Biosimilar Development and the BPCI Act: Guidance for Industry10/9/2026
- Study Data Technical Conformance Guide - Technical Specifications Document10/8/2026